VarCT Diagnostics ApS: Financial statements 2019
CVR: 38733567
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
VarCT Diagnostics ApS (CVR 38733567) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK -2,020,592 and a net result of DKK -3,221,331 compared with DKK -1,767,180 the year before. Equity in the 2019 report amounted to DKK 9,503,072. The solvency ratio was 79.2%. The company had 3 employees in the financial year.
- Gross Profit
- DKK -2,020,592
- Profit/Loss
- DKK -3,221,331
- Equity
- DKK 9,503,072
- Total Assets
- DKK 12,003,853
- Employees
- 3
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | -2 mio. | -3.2 mio. | 9.5 mio. | 3 |
| 2018 | - | -472 t. | -1.8 mio. | 12.7 mio. | 2 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
VarCT Diagnostics ApS has published its annual report for 2018. Gross profit came to DKK -472,235, and the net result was DKK -1,767,180.
About VarCT Diagnostics ApS
VarCT Diagnostics ApS is a Danish company of the type Anpartsselskab based in Frederiksberg, founded in 2017. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Ali El-Salanti and Mads Daugaard. The board consists of Mads Daugaard (chair), Ali El-Salanti, Josef Rainer and Peter Schröcksnadel. The company is owned by VAR2 PHARMACEUTICALS ApS and Sitour Management m.b.H.. The company has 4 employees (2018). In 2025, the company reported a gross profit of DKK 176,862 and a net result of DKK -1,961,493 compared with DKK 779,245 the year before. Equity in the 2025 report amounted to DKK 2,238,264.